Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Smoking in the Pathogenesis of Multiple Sclerosis: A Review Article
Nishanth Katukuri, Ezza Tariq, Farirai P Nzvere, et al.
Cureus (2020)
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
Еlena V. Mitroshina, Maria O. Savyuk, Evgeni Ponimaskin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 84
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges
Zuber Khan, Ghanshyam Das Gupta, Sidharth Mehan
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4274-4274
Open Access | Times Cited: 31
The Potential of Transcranial Direct Current Stimulation (tDCS) in Improving Quality of Life in Patients with Multiple Sclerosis: A Review and Discussion of Mechanisms of Action
James Chmiel, Donata Kurpas, Marta Stępień-Słodkowska
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 373-373
Open Access | Times Cited: 1
A systematic review of Mendelian randomization studies on multiple sclerosis
Teresa Fazia, Giulia Nicole Baldrighi, Andrea Nova, et al.
European Journal of Neuroscience (2023) Vol. 58, Iss. 4, pp. 3172-3194
Open Access | Times Cited: 12
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence
Rolf Pringler Holm, Malthe Faurschou Wandall‐Holm, Melinda Magyari
Brain (2024)
Open Access | Times Cited: 4
The Probable Infectious Origin of Multiple Sclerosis
Remi L. Landry, Monica E. Embers
NeuroSci (2023) Vol. 4, Iss. 3, pp. 211-234
Open Access | Times Cited: 10
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical Trials
Ashwani, Anjali Sharma, Mayank Kumar Choudhary, et al.
Molecular Neurobiology (2025)
Open Access
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?
Arianna Di Stadio, Evanthia Bernitsas, Ignazio La Mantia, et al.
Life (2023) Vol. 13, Iss. 1, pp. 226-226
Open Access | Times Cited: 9
Review on theranostic and neuroprotective applications of nanotechnology in multiple sclerosis
Anshul Sharma, Nitin Sharma, Sachin Kumar Singh, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104220-104220
Closed Access | Times Cited: 8
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis
Elisabetta D’Aversa, Francesca Salvatori, Mauro Vaccarezza, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1316-1316
Open Access | Times Cited: 2
The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank
Camilla Barbero Mazzucca, Lorenza Scotti, Cristoforo Comi, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1746-1746
Open Access | Times Cited: 1
Enhancing brain health: Swimming-induced BDNF release and epigenetic influence in MS female mouse models
Soheila Banasadegh, Shahnaz Shahrbanian, Reza Gharakhanlou, et al.
Journal of Ethnicity in Substance Abuse (2024), pp. 1-17
Closed Access | Times Cited: 1
Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study
Naghmeh Abbasi Kasbi, Sajjad Ghane Ezabadi, Kosar Kohandel, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control study
Laura Moles, Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00457-e00457
Open Access | Times Cited: 1
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
Sara Fathallah, Ahmed Abdellatif, Mona Kamal Saadeldin
Medicine International (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 2
Early postnatal tobacco smoke exposure aggravates experimental autoimmune encephalomyelitis in adult rats
Zhaowei Wang, Liping Wang, Fangfang Zhong, et al.
Neurochemistry International (2020) Vol. 141, pp. 104892-104892
Open Access | Times Cited: 3
The Influence of Parenting and Social Environment on Bullying
Wiwik Hidayati Jaya, Muhammad Syahrul Alam, Robertus Masyhuri, et al.
An Idea Nursing Journal (2024) Vol. 3, Iss. 01, pp. 06-11
Open Access
The Relationship of Family Role With Smoking Behaviour in Adolescent
Ambo Anto, Firman Telaumbanua, S Sapriadi, et al.
An Idea Nursing Journal (2024) Vol. 3, Iss. 01, pp. 01-05
Open Access
Prevalence of sexual disorders in relapsing-remitting multiple sclerosis patients depending on various risk factors
Tetiana A. Odintsova, О.О. Kopchak
Romanian Journal of Medical Practice (2024) Vol. 19, Iss. 1, pp. 68-72
Open Access
An extensible and unifying approach to retrospective clinical data modeling: the BrainTeaser Ontology
Guglielmo Faggioli, Laura Menotti, Stefano Marchesin, et al.
Journal of Biomedical Semantics (2024) Vol. 15, Iss. 1
Open Access
The role of vitamin D in multiple sclerosis and its mechanisms of action
Agata Kowalczyk, Justyna Kiełbasa, Magda Przestrzelska, et al.
Quality in Sport (2024) Vol. 19, pp. 54188-54188
Open Access
Multiple Sclerosis: An Overview of Epidemiology, Risk Factors, and Serological Biomarkers
Ming-Cheng Shi, Y Liu, Qiuyue Gong, et al.
Acta Neurologica Scandinavica (2024) Vol. 2024, Iss. 1
Open Access
Vitamin D and Multiple Sclerosis; Is There a Real Association?
Mustafa Mohammed Al Brahim, Omar Muhammed Aldosari, Saeed Ali Saeed Alyahya, et al.
International Journal Of Pharmaceutical Research And Allied Sciences (2021) Vol. 10, Iss. 2, pp. 129-133
Open Access | Times Cited: 2
The Role of Ocrelizumab in Multiple Sclerosis Treatment
Rawan Hamdan Salem Alenazy, Mohammed Majed S Abualshamat, Fahad Sh S Dh Alqahs, et al.
Archives of Pharmacy Practice (2021) Vol. 12, Iss. 3, pp. 117-120
Open Access | Times Cited: 2
Non-HLA Genes and Multiple Sclerosis
Jamilah Borjac, Alaa Matar, Maxime Merheb, et al.
The Open Biotechnology Journal (2023) Vol. 17, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top